ArticleThe Journal of clinical investigation2017

Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.

Marielle Brockhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.